Ngubani na uTomas Hodgkin?
Ubani ubuso obusemva kweHodgkin lymphoma ? UThomas Hodgkin (1798-1866) wayengumhlengikazi waseBrithani owaqala ukuchaza lesi sifo ekuqaleni kwawo-1800.
UThomas Hodgkin wayengomnye wabantu abaqaqambileyo baseBrithani bexesha lakhe, ukufundisa nokucwangcisa imyuziyamu yezilwanyana e-Guy Hospital Hospital School eLondon. Wenza amakhulu eemotopi kwaye wakhathaza amawaka eemifanekiso.
Kwakhona wazisa i-stethoscope yokuqala kwiSibhedlele saseGuy emva kokuyalelwa ngendlela esasetyenziswa ngayo nguRené Laennec eParis.
Ukuchaza nokubiza igama elithi Hodgkin Lymphoma
Ngomsebenzi wakhe kwimyuziyam yoluntu, wafunda wagcina iimpawu zeziluntu ezithintekayo kwizifo ezahlukileyo. Ngomnyaka we-1832, wapapasha iphepha elichaza uhlobo lwesifo kwi-lymph nodes kunye neentente ecinga ukuba sisifo esithile kunokusuleleka. Eli phepha, elinesihloko esithi "Kweminye imibala ye-Glands ye-Absorbent Glands ne-Spleen," yashicilelwa kwiNcwadi yeZonyango kunye ne-Chirurgical Society eLondon .
Ngeli xesha lokupapashwa, eli phepha lahamba lingabonakali. Kwiminyaka engaphezu kweminyaka emithathu kamva, ngo-1865, omnye ugqirha waseBritani, uSamuel Wilks, wachaza isifo esifanayo. Ngethuba ekhangele phambili kumaphepha angaphambili, wabona ukuba uHodgkin wayifumene nesifo phambi kwakhe. Wabiza lesi sifo emva koHodgkin.
Ukususela ngoko, lo mhlaza we- lymph nodes unalo negama.
Kwaphela iminyaka engama-100 kwabizwa ngokuba yi-Hodgkin's disease okanye i-lodphokin ye-Hodgkin. Kwiminyaka yakutshanje, izinto eziphathekayo ziye zahlulwa kwaye zibizwa ngokuba yiHodgkin lymphoma kunye ne-non-Hodgkin lymphoma. Uza kubona iifom zombini zisetyenziswa namhlanje, kodwa zonke zibhekisela kwisifo esifanayo.
Ubomi Nomsebenzi kaThomas Hodgkin
UThomas Hodgkin unamathuba amaninzi kumboleko wakhe kunokuba achaze iHodgkin lymphoma. Kwakhona wachaza okokuqala i-appendicitis enobuchule kunye nokuntuleka kwe-aortic, isifo senhliziyo. Wabhala iincwadana eziliqela zokufunda, kuquka enye ekusabalaleni komhlaza kwimiphunga kunye nesisu.
Wabambisana noJoseph J. Lister (uyise we-optic surgery) kwaye wasebenzisa i-lens microscope yakhe yokuphucula ukufumana ukuba iiselom zegazi ezibomvu zinesimo se-biconcave kwaye iimbumba ze-muscle zixhatshazo. Amaphepha abo acingelwa ngabanye ukuba isiseko se-histology yanamhlanje, ukufundwa kwe-microscopic anatomy yeeseli. Kuyathakazelisa, akazange ahlolisise i-lymph nodes echazwe kwi-lymphoma ngaphantsi kwe-microscope, nangona uhlalutyo lwamatyala malunga neminyaka eyi-100 kamva lwaqinisekisa ukuba yi-Hodgkin lymphoma kunye ne- non-Hodgkin lymphoma .
UHodgkin wayevela kwintsapho yaseQuaker ezinikeleyo kwaye kwasekuqaleni wabhala ngokungabi nabulungisa kwentlalo kunye nokungalingani ngokobuzwe. Wayengumxhasi omkhulu wonyango lwentlalo kunye nobubele. IHodgkin efundiswe kwiKholeji yezoLimo kaGuyra ekukhuthazeni impilo yezempilo ngomoya ococekileyo, ukuhlamba kunye nokulahlwa kwamanzi. Wakhuthaza iindlela zokuphila zokuthintela kuquka ukuzilolonga rhoqo kunye nokuphepha ukutywala, ukusela utswala nokutshaya.
Wahamba ehlabathini kunye nomhlobo wakhe kunye noMoses Montefiore, ukuqeqesha ngamanyathelo okucoceka kunye nokunceda amaYuda nabanye abantu abacinezelweyo. Okumangalisayo kukuba, wafa ngenxa yesifo somhlaza-njengesifo ngexesha lokutyelela ePalestina ngo-1866. Uncwatyelwe eJaffa.
Izifo zikaThomas Hodgkin, namhlanje
Namhlanje, inkqubela eyenziwe kwenzululwazi nakwiyeza ngenxa yokuba amaxesha kaThomas Hodgkin ayengaqiniseki kuye. Kwaye, ngokuqinisekileyo kukho indawo yokuphucula.
Isifo se-Hodgkin ngoku sithathwa njengenye yezinto ezinomdla kakhulu kunye nokwelapha, kwaye ihlala ihamba kakuhle. Oku akunjalo kuzo zonke iimeko, nangona kunjalo, kwaye i-HL isathatha ubomi.
I-American Cancer Society ilinganisela ukuba ngowama-2017, iimeko ezitsha ezingama-8,260 zafunyaniswa kwaye kwakukho ukufa kwabangu-1,070 kulo mhlaza.
Imithombo:
I-King's College yaseLondon, iwebhusayithi yeYunivesithi yaseLondon: "Imbali yeKholeji yeKholeji - uThomas Hodgkin."
UMarvin J. Stone, MD. "UThomas Hodgkin: unobulunga olungapheliyo kunye nomoya ongenakuzimela." Proc (iBayl Univ Med Cent). 2005 Oct; 18 (4): 368-375.